Molsidomine (Corvaton)
Eliseev, O.M.
Terapevticheskii Arkhiv 66(9): 82-88
1994
ISSN/ISBN: 0040-3660 PMID: 7992225 Document Number: 428393
Document emailed within 1 workday
Related Documents
Petrov, D.V. 1987: Long-term use of the peripheral vasodilator corvaton in the polyclinic stage of rehabilitation of patients with myocardial infarction and subclinical manifestations of circulatory insufficiency (clinico-hemodynamic study) Terapevticheskii Arkhiv 59(4): 108-112Just, M.; Martorana, P.A.; Nitz, R.E. 1987: Inhibition of platelet functions by molsidomine in animals Pathologie-Biologie 35(2 Part 2): 226-228
Grodzinska, L.; Basista, M.; Koenig, E. 1987: Antithrombotic properties of the active metabolite of molsidomine, SIN-1 Pathologie-Biologie 35(2 Part 2): 233-234
Kmieć, M.; Ochmański, W. 1998: Molsidomine: importance in treatment of circulation disorders Przeglad Lekarski 55(10): 532-536
Hackl, W.; Frohner, K.; Podczek, A.; Unger, G.; Steinbach, K. 1986: Effect of molsidomine on hemodynamics in patients with dilated cardiomyopathy Wiener Klinische Wochenschrift 98(17): 581-584
Klöcking, H.P.; Hoffmann, A.; Markwardt, F. 1987: Release of plasminogen activator by molsidomine and its active metabolite SIN-1 Die Pharmazie 42(5): 354
Lehmann, G.; Reiniger, G.; Beyerle, A.; Schömig, A. 1998: Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine Journal of Cardiovascular Pharmacology 31(1): 25-30
Korda, P.; Barnert, J.; Schmidbaur, W.; Wienbeck, M. 1994: Effect of molsidomine on esophageal motility in patients with non-cardiac thoracic pain Medizinische Klinik 89(Suppl 2): 73-74
Rotrekl, P.; Lupínek, Z.; Meluzín, J.; Rysavý, F.; Lupínková, Z. 1989: The effect of molsidomine on bicycle ergometry in patients with stable angina pectoris Vnitrni Lekarstvi 35(12): 1195-1202
Degtiarev, O.A.; Ivanov, A.I.; Sotskova, T.V.; Mikerova, T.M. 1990: Nifedipine and molsidomine treatment of circulatory insufficiency in elderly patients with hypertension Sovetskaia Meditsina 4: 57-59
Vakaliuk, I.P. 1986: Biorhythm influence on the course of ischemic heart disease during combined treatment with molsidomine and anaprilin Terapevticheskii Arkhiv 58(12): 49-50
Grosse-Heitmeyer, W.; Huber, T.; Ostrowski, J. 1993: Molsidomine in chronic heart failure with liver congestion--oral or intravenous therapy? Medizinische Klinik 88(1): 21-25
Huber, T.; Grosse-Heitmeyer, W.; Rietbrock, S.; Harder, S. 1992: Pharmacokinetics and pharmacodynamics of molsidomine in patients with liver dysfunction due to congestive heart failure International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 491-492
Gryglewski, R.J.; Swies, J.; Chłopicki, S.; Niezabitowski, P. 1993: Permissive effect of molsidomine towards cardioprotective action of iloprost in myocardial ischemia in cats Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 44(3): 313-318
Drummer, C.; Valta-Seufzer, U.; Spannagl, M.; Frey, A.; Lüdke, S.; Schramm, W.; Gerzer, R. 1991: Thrombocyte aggregation and fibrinolysis in healthy probands treated with molsidomine, isosorbide-5-mononitrate and placebo Zeitschrift für Kardiologie 80(Suppl 5): 43-46
Stoschus, B.; Fernandez, I.; Heller, J.; Neubrand, M.; Sauerbruch, T. 1999: Prediction of the lower esophageal sphincter pressure after oral molsidomine by sydnonimine plasma concentrations Hepato-Gastroenterology 46(26): 933-937
Haerer, W.; Henze, E.; Stauch, M. 1989: The effect of a combination of ridazolol and molsidomine on hemodynamics and left ventricular function in dilated cardiomyopathy Arzneimittel-Forschung 39(6): 714-716
Belhassen, L.; Carville, C.; Pelle, G.; Sediame, S.; Benacerraf, S.; Dubois-Randé, J.L.; Adnot, S. 2000: Molsidomine improves flow-dependent vasodilation in brachial arteries of patients with coronary artery disease Journal of Cardiovascular Pharmacology 35(4): 560-563
Jansen, W.; Eggeling, T.; Meyer, L.; Tauchert, M.; Hilger, H.H. 1987: Acute and chronic effects of molsidomine on pulmonary artery pressure and work capacity in patients with coronary heart disease European Heart Journal 8(8): 870-877
Lampert, E.; Tuo, N.; Frans, A.; Lonsdorfer, J. 1991: Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment Pathologie-Biologie 39(1): 29-33